{"protocolSection":{"identificationModule":{"nctId":"NCT06482814","orgStudyIdInfo":{"id":"24-001204"},"secondaryIdInfos":[{"id":"1R01HL169320-01A1","type":"NIH","link":"https://reporter.nih.gov/quickSearch/1R01HL169320-01A1"}],"organization":{"fullName":"Mayo Clinic","class":"OTHER"},"briefTitle":"Sleep Restriction and Parental History of Hypertension","officialTitle":"Sleep Restriction and Parental History of Hypertension"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-07","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2028-04","type":"ESTIMATED"},"completionDateStruct":{"date":"2028-04","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-26","studyFirstSubmitQcDate":"2024-06-26","studyFirstPostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2024-06-26","lastUpdatePostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Naima Covassin","investigatorTitle":"Principal Investigator","investigatorAffiliation":"Mayo Clinic"},"leadSponsor":{"name":"Mayo Clinic","class":"OTHER"},"collaborators":[{"name":"National Heart, Lung, and Blood Institute (NHLBI)","class":"NIH"}]},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this study is to research the effects of partial sleep deprivation (sleep restriction) in a group of individuals whose parents have high blood pressure compared to a group of individuals whose parents have normal blood pressure."},"conditionsModule":{"conditions":["Hypertension"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"CROSSOVER","primaryPurpose":"OTHER","maskingInfo":{"masking":"DOUBLE","whoMasked":["INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":44,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Study Sequence AB","type":"EXPERIMENTAL","description":"Sleep restriction condition in the first period and normal sleep condition in the second period. Each period will consist of a 10-day inpatient visit comprising a 3-day/2-night baseline, followed by a 5-day/5-night experimental phase, and a 2-day/2-night recovery phase.","interventionNames":["Behavioral: Partial sleep deprivation (sleep restriction)","Behavioral: Normal sleep"]},{"label":"Study Sequence BA","type":"EXPERIMENTAL","description":"Normal sleep condition in the first period and sleep restriction condition in the second period. Each period will consist of a 10-day inpatient visit comprising a 3-day/2-night baseline, followed by a 5-day/5-night experimental phase, and a 2-day/2-night recovery phase.","interventionNames":["Behavioral: Partial sleep deprivation (sleep restriction)","Behavioral: Normal sleep"]}],"interventions":[{"type":"BEHAVIORAL","name":"Partial sleep deprivation (sleep restriction)","description":"During the experimental segment the sleep opportunity will be restricted to 5 hours/night. During the acclimation and recovery phases a 9-hour/night sleep opportunity will be provided.","armGroupLabels":["Study Sequence AB","Study Sequence BA"]},{"type":"BEHAVIORAL","name":"Normal sleep","description":"During the normal sleep condition a 9-hour/night sleep opportunity will be provided throughout the 10-day inpatient visit.","armGroupLabels":["Study Sequence AB","Study Sequence BA"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"24-hour Systolic Blood Pressure (BP)","description":"Systolic Blood pressure will be measured in mmHg","timeFrame":"Day 2, Day 4, Day 7, and Day 9"}],"secondaryOutcomes":[{"measure":"24-hour Diastolic blood pressure (DBP)","description":"Diastolic blood pressure will be measured in mmHg","timeFrame":"Day 2, Day 4, Day 7, and Day 9"},{"measure":"Awake Systolic Blood Pressure/Diastolic Blood Pressure (SBP/DBP)","description":"Awake SBP/DBP will be measured in mmHg/mmHg","timeFrame":"Day 2, Day 4, Day 7, and Day 9"},{"measure":"Asleep Systolic Blood Pressure/Diastolic Blood Pressure (SBP/DBP)","description":"Asleep SBP/DBP will be measured in mmHg/mmHg","timeFrame":"Day 2, Day 4, Day 7, and Day 9"},{"measure":"Systolic Blood Pressure/Diastolic Blood Pressure (SBP/DBP) Nocturnal dipping","description":"SBP/DBP Nocturnal dipping will be measured in percent (%)","timeFrame":"Day 2, Day 4, Day 7, and Day 9"},{"measure":"Catecholamines","description":"Catecholamines will be measured from a 24-hour urine collection.","timeFrame":"Day 2, Day 4, Day 7, and Day 9"},{"measure":"Baroreflex Sensitivity","description":"Baroreflex Sensitivity will be measured from simultaneous electrocardiography (ECG) and noninvasive beat-to-beat BP recording.","timeFrame":"Day 3, Day 5, Day 8, and Day 10"},{"measure":"Endothelial Function","description":"Endothelial function will be estimated from flow-mediated vasodilation using ultrasound.","timeFrame":"Day 3, Day 5, Day 8, and Day 10"},{"measure":"Blood Pressure (BP) response to stressors","description":"BP response to stressors will be measured in mmHg","timeFrame":"Day 3, Day 5, Day 8, and Day 10"},{"measure":"Heart Rate response to stressors","description":"Heart Rate response to stressors will be measured by ECG","timeFrame":"Day 3, Day 5, Day 8, and Day 10"},{"measure":"DNA-methylation","description":"Methylated gene markers in peripheral blood mononuclear cells will be obtained","timeFrame":"Day 3, Day 5, Day 8, and Day 10"},{"measure":"Transcriptomic","description":"Whole transcriptome in peripheral blood mononuclear cells will be obtained","timeFrame":"Day 3, Day 5, Day 8, and Day 10"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria\n\n* Healthy adults aged 18-35 years\n* Absence of any significant medical or psychiatric disease (as per the investigators' judgment)\n* Nonsmoker\n* Nonpregnant\n* History of normal sleep duration (reported average sleep duration between 7-9 hours/night and no habitual napping)\n* Both biological parents receiving care at Mayo Clinic Rochester\n* Ability to understand study procedures and to comply with them for the entire length of the study\n* Ability to understand English and provide informed consent\n\nExclusion Criteria\n\n* Age \\<18 or \\>35 years\n* Body mass index \\<18.5 or ≥30 kg/m2\n* Pregnant or lactating\n* Unable to determine history of HTN in participant's biological parents or subject being adopted\n* Use of tobacco, marijuana products or vaping\n* Excessive caffeine consumption (\\>400 mg/day)\n* Excessive alcohol consumption (\\>7 drinks/week for women, \\>14 drinks/week for men)\n* Office SBP/DBP ≥130/80 mmHg\n* Daytime ambulatory SBP/DBP ≥130/80 mmHg\n* Fasting glucose ≥126 mg/dl\n* Glomerular filtration rate \\<60 mL/min/BSA\n* History of significant medical or psychiatric disorders (as per the investigators' judgment)\n* Regular use of prescription medications other than contraceptives\n* Use of melatonin supplements or any other over-the-counter sleep aid\n* Moderate-to-severe sleep disordered breathing (apnea/hypopnea index, AHI ≥15) or mild sleep disordered breathing (AHI 5-15) with daytime sleepiness (Epworth Sleepiness Scale \\>10)\n* Moderate-to-severe insomnia (Insomnia Severity Index \\>14)\n* Restless leg syndrome (as per the Cambridge-Hopkins questionnaire)\n* Excessive daytime sleepiness (Epworth Sleepiness Scale \\>15)\n* Extreme chronotype (Morningness-Eveningness Questionnaire \\>69 or \\<31)\n* Night shift work\n* Habitual high levels of physical activity (\\>3000 MET×minutes/week)125\n* Ongoing participation in other research studies (as per the investigators' judgment)\n* Any other medical, geographic, or social factor making study participation impractical\n* Not English-speaking and/or inability to provide informed consent\n* Exclusionary for blood draws: hemoglobin \\<12 g/dL in women / \\<13.5 g/dL in men; participants with measured hemoglobin levels below these thresholds will be allowed to continue participate in study tests and procedures not involving blood draws.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"35 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Naima Covassin, Ph.D","affiliation":"Mayo Clinic","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Mayo Clinic in Rochester","city":"Rochester","state":"Minnesota","zip":"55905","country":"United States","geoPoint":{"lat":44.02163,"lon":-92.4699}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000006973","term":"Hypertension"}],"ancestors":[{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M10024","name":"Hypertension","asFound":"Hypertension","relevance":"HIGH"},{"id":"M17400","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}